Menu
GeneBe

MT1X

metallothionein 1X, the group of Metallothioneins

Basic information

Region (hg38): 16:56682469-56684196

Previous symbols: [ "MT1" ]

Links

ENSG00000187193NCBI:4501OMIM:156359HGNC:7405Uniprot:P80297AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MT1X gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MT1X gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
3
clinvar
1
clinvar
4
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 3 1 0

Variants in MT1X

This is a list of pathogenic ClinVar variants found in the MT1X region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-56682560-G-C not specified Uncertain significance (Jun 06, 2022)2294160
16-56683200-A-G not specified Uncertain significance (May 17, 2023)2547608
16-56683239-A-G MT1X-related disorder Likely benign (Mar 29, 2019)3058797
16-56683993-T-A not specified Uncertain significance (Oct 12, 2021)2254602
16-56684030-A-T not specified Uncertain significance (Mar 21, 2024)3296503

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MT1Xprotein_codingprotein_codingENST00000394485 31773
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0009340.36912561501241257390.000493
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2382932.80.8830.00000154397
Missense in Polyphen44.61750.8662744
Synonymous-0.3881513.21.147.04e-7101
Loss of Function-0.41343.201.251.35e-744

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0004950.000495
Ashkenazi Jewish0.001790.00179
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.0006680.000668
Middle Eastern0.000.00
South Asian0.0003270.000327
Other0.0006520.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. May be involved in FAM168A anti-apoptotic signaling (PubMed:23251525). {ECO:0000269|PubMed:23251525}.;
Pathway
Mineral absorption - Homo sapiens (human);Copper homeostasis;Zinc homeostasis;Oxidative Stress;Response to metal ions;Cellular responses to external stimuli;Metallothioneins bind metals (Consensus)

Intolerance Scores

loftool
0.721
rvis_EVS
0.24
rvis_percentile_EVS
68.72

Haploinsufficiency Scores

pHI
0.117
hipred
N
hipred_score
0.146
ghis
0.393

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.575

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mt1
Phenotype
vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype;

Gene ontology

Biological process
cellular zinc ion homeostasis;response to metal ion;detoxification of copper ion;cellular response to erythropoietin;negative regulation of growth;cellular response to cadmium ion;cellular response to copper ion;cellular response to zinc ion
Cellular component
nucleus;cytoplasm;perinuclear region of cytoplasm
Molecular function
protein binding;zinc ion binding;metal ion binding